Digital vaccines use applications through smart-phones, tablets and other similar devices to advance positive human behavior through neurocognitive training. Mr. Prakash, founder of LifeScience startup FriendsLearn, has recently received a patent for ‘Systems and Methods for Digital Vaccines’ which he has developed as part of it. Carnegie Mellon UniversityNo digital vaccine project.
The work involves use Artificial intelligence And a gamified Metavers platform.
“It’s a milestone in the field of digital vaccine science. It is also an unusual landmark for the biomedical innovation of Indian deep tech startups on the world stage. The platform has wide application – it could potentially block a wide spectrum of diseases ranging from covid-19 and influenza to diabetes, cardiovascular disease, hypertension and certain cancers and cognitive diseases, “said Mr. Prakash, who is from Chennai. Says.
Mr. Prakash’s mobile game fooya !, developed using patented technology, has been used to conduct clinical trials on children between the ages of 3 and 18. In the game, the child is a superhero fighting junk food which is being developed by an evil scientist. Kids playing fuya! Choose significantly healthier foods immediately for only 20 minutes a week, and subsequent weekly sessions reproduce positive health results.
Digital vaccines are currently being deployed around the world among selected school partners of Carnegie Mellon project. Bhargava applied for a patent in the United States about five years ago. Its patent applications are pending in India, Europe, China, Australia, Canada and New Zealand.
Rahul Ladhania, Data Science Researcher and Faculty Member University of Michigan The School of Public Health notes that sports-based education is not exactly a novel, in which analog and digital games are studied in multiple settings (classrooms, clinics, etc.) to promote physical activity, nutritional knowledge, and healthy eating. “But what separates the digital vaccine from its implicit learning and neurocognitive training mechanism components is that it can induce biomarker-level changes in individuals, thus helping to trigger lifestyle habits formation, and reduce the risk and incidence of diseases,” he said. Says.
Researchers at his school – home of the world’s first polio vaccine – are evaluating health outcomes from the novel vaccine platform.
While most interventions with technology have so far focused on children, Ladhania says, “this is easily accepted and can be extended to applications for the prevention or treatment of a wide range of pathologies – such as post-traumatic stress disorder, mental health, Sexual health. – and for a variety of targeted populations. ”
